Forensic Genomics Market Size, Growth, Trends | Report 2022-2030
The forensic genomics market is anticipated to witness significant growth as the majority of companies aim to use customer databases in combination with cutting-edge sequencing technologies. It aims to accelerate the adoption and validation of innovative methods to support investigations that are not possible with traditional testing methods. Some of the factors that are driving the growth of the market are increasing investments to support the forensics program, growth in government initiatives, along with increasing sampling methods and portable equipment. For instance, in December 2021, the National Institute of Justice funded USD 17 million to support 36 R&D projects in the year 2020. However, the high cost of these instruments is anticipated to hamper the growth of the market.
Many forensic science areas, including DNA analysis, are transforming in the US and the around the globe. New techniques are being validated, created, and implemented to assist criminal investigations. Investigators usually face issues regarding the accuracy and validity of current and older methods. For instance, Illumina, Inc. partnered with Telegraph Hill Partners to boost the adoption of NGS in the forensic genomics market. Some of the applications include disaster victim identification, DNA database management, missing person identification, criminal casework, f mtDNA analysis, and SNP and STR sequencing.
Furthermore, criminal testing application is anticipated to grow rapidly in the coming years. With the increasing number of crimes around the globe, the demand for forensic genomics is projected to increase significantly. For instance, according to the data published in Statistics Canada, it stated that there were around 743 cases of homicides reported in 2020. The homicide rate increased by 7% from 1.83 per 100,000 people in 2019 to 1.95 in 2020, making it the highest rate since 2005.
Several initiatives by key market players are driving the market growth. For instance, in August 2022, Thermo Fisher Scientific, inc collaborated with National Forensic Sciences University to set up the Centre of Excellence for DNA Forensics in Gujrat, India. The facility is fully equipped with end-to-end workflows, which are supported by advanced technology. Similarly, in August 2022, Gene by Gene and Verogen, Inc. entered into the partnership agreement to accelerate the forensic investigative genetic genealogy adoption. This alliance would further offer to standardize bioinformatic methods and cost-effective whole genome sequencing services for FIGG analysis for difficult forensic samples.
Key Players
Market Segmentation
Forensic Genomics Market
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Forensic Genomics Market
5.1. COVID-19 Landscape: Forensic Genomics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Forensic Genomics Market, By Solution
8.1. Forensic Genomics Market, by Solution, 2022-2030
8.1.1 Kits
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Analyzers & Sequencers
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Software
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Consumable
8.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Forensic Genomics Market, By Method
9.1. Forensic Genomics Market, by Method, 2022-2030
9.1.1. Capillary Electrophoresis (CE)
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Next-generation Sequencing (NGS)
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. PCR Amplification
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Forensic Genomics Market, By Application
10.1. Forensic Genomics Market, by Application, 2022-2030
10.1.1. Criminal Testing
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Paternity & Familial Testing
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Forensic Genomics Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Solution (2017-2030)
11.1.2. Market Revenue and Forecast, by Method (2017-2030)
11.1.3. Market Revenue and Forecast, by Application (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Solution (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Method (2017-2030)
11.1.4.3. Market Revenue and Forecast, by Application (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Solution (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Method (2017-2030)
11.1.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Solution (2017-2030)
11.2.2. Market Revenue and Forecast, by Method (2017-2030)
11.2.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Solution (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Method (2017-2030)
11.2.4.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Solution (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Method (2017-2030)
11.2.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Solution (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Method (2017-2030)
11.2.6.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Solution (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Method (2017-2030)
11.2.7.3. Market Revenue and Forecast, by Application (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Solution (2017-2030)
11.3.2. Market Revenue and Forecast, by Method (2017-2030)
11.3.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Solution (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Method (2017-2030)
11.3.4.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Solution (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Method (2017-2030)
11.3.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Solution (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Method (2017-2030)
11.3.6.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Solution (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Method (2017-2030)
11.3.7.3. Market Revenue and Forecast, by Application (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Solution (2017-2030)
11.4.2. Market Revenue and Forecast, by Method (2017-2030)
11.4.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Solution (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Method (2017-2030)
11.4.4.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Solution (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Method (2017-2030)
11.4.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Solution (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Method (2017-2030)
11.4.6.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Solution (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Method (2017-2030)
11.4.7.3. Market Revenue and Forecast, by Application (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Solution (2017-2030)
11.5.2. Market Revenue and Forecast, by Method (2017-2030)
11.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Solution (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Method (2017-2030)
11.5.4.3. Market Revenue and Forecast, by Application (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Solution (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Method (2017-2030)
11.5.5.3. Market Revenue and Forecast, by Application (2017-2030)
Chapter 12. Company Profiles
12.1. GE Healthcare
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Thermo Fisher Scientific, inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Agilent Technologies, inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Eurofins Discovery
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Gene by Gene, Ltd.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Verogen, Inc
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Illumina, Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Neogen Corporation
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers